About this trial
Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.
Eligibility criteria
Qualifiers
Adolescents age 12-17 years.
Atopic dermatitis refractory to standard topical treatment including topical steroids or topical calcineurin inhibitors.
Moderate to severe atopic dermatitis via PO-SCORAD score on enrollment.
Disqualifiers
Started on a biologic agent (i.e. dupxient) within the past 3 months.
Mild atopic dermatitis via PO-SCORAD score on enrollment.
Trial design
Treatments tested in this trial
- Digital App Mindfulness Meditation
- Mindfulness Meditation Sheet
Treatment groups
Sponsors and collaborators
Weill Medical College of Cornell University
Lead sponsor
Columbia University
Collaborator